REAL

γ-Cyclodextrin enhances the biopharmaceutical performance of Boswellia serrata extract: comparative in vitro and ex vivo evaluation

Stifter-Mursits, Marcell and Püski, Péter and Bárdos, Vivien and Ádám, Barbara and Szőcs, Levente and Hamar, Dávid and Kállai-Szabó, Nikolett and Antal, István and Hohmann, Judit and Hunyadi, Attila and Chang, Fang-Rong and Sipos, Bence and Katona, Gábor and Angi, Réka and Balogh, György T. (2026) γ-Cyclodextrin enhances the biopharmaceutical performance of Boswellia serrata extract: comparative in vitro and ex vivo evaluation. PHARMACEUTICAL BIOLOGY, 64 (1). pp. 1222-1244. ISSN 1388-0209

[img]
Preview
Text
_CyclodextrinenhancesthebiopharmaceuticalperformanceofBoswelliaserrataextractcomparativeinvitroandexvivoevaluation-2-24.pdf - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

Context Poor oral bioavailability of boswellic acids (BAs) restricts the therapeutic potential of Boswellia serrata extracts (BSE), primarily due to low solubility and limited intestinal absorption. Objective This study systematically evaluated cyclodextrin (CD)-based BSE formulations to identify a composition with the potential to enhance the biopharmaceutical performance of BAs. Materials and methods Native and substituted CDs were screened for BA solubilization. Selected BSE formulations were prepared by lyophilization and physical mixing and characterized using HPLC, FT-IR, PXRD and DSC. Dissolution was evaluated in fasted- and fed-state biorelevant media, followed by intestinal parallel artificial membrane permeability assay (PAMPA) and ex vivo porcine intestinal permeation studies. Results The greatest solubility enhancements were provided by γ-CDs. Lyophilizates markedly enhanced BA dissolution, with approximately 8–10-fold higher release in fasted-state medium and complete release in fed-state medium. In PAMPA, HP-γ-CD increased apparent BA permeability by up to 3–5-fold in fasted-state medium, versus 1.7–2.8-fold for native γ-CD. Conversely, ex vivo studies identified native γ-CD as the superior carrier, increasing cumulative BA permeation approximately 15-fold. Discussion The superior performance of γ-CDs is consistent with the hypothesis that their larger cavity provides favorable accommodation of bulky BAs. The contrasting PAMPA and ex vivo outcomes indicate that biopharmaceutical performance depends on the balance between solubilization, free-drug availability and membrane interactions rather than solubilization capacity alone. Conclusion Native γ-CD demonstrated the most favorable overall performance, particularly in the ex vivo permeation model, supporting further evaluation of its potential to improve intestinal absorption of BAs.

Item Type: Article
Uncontrolled Keywords: Boswellia serrata extract, boswellic acids, γ-cyclodextrin inclusion complex, in vitro dissolution, ex vivo intestinal permeation
Subjects: R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan
SWORD Depositor: MTMT SWORD
Depositing User: MTMT SWORD
Date Deposited: 21 Nov 2026 23:01
Last Modified: 21 Nov 2026 23:01
URI: https://real.mtak.hu/id/eprint/250448

Actions (login required)

View Item View Item